UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Nosocomial postsurgical meningitis in children: a 12-year survey comparing data from 1993-1998 with data from 1999-2004

Infection control and hospital epidemiology, 2006-07, Vol.27 (7), p.788

2006

Volltextzugriff (PDF)

Infective endocarditis in diabetic patients

Scandinavian journal of infectious diseases, 2005, Vol.37 (11-12), p.958-958

2005

Volltextzugriff (PDF)

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK , ROS1 , and ALK fusion-positive solid tumors

Therapeutics and clinical risk management, 2018-01, Vol.14, p.1247-1252

2018

Volltextzugriff (PDF)

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study

Journal of thrombosis and thrombolysis, 2017-02, Vol.43 (2), p.166-171

2017

Volltextzugriff (PDF)

Pharmacotherapy for chronic myelogenous leukemia: a case-based approach

Journal of the National Comprehensive Cancer Network, 2011-02, Vol.9 Suppl 3, p.S25

Harnicar, Stephen

2011

Volltextzugriff (PDF)

Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer

The American journal of cardiology, 2017-07, Vol.120 (2), p.213-217

2017

Volltextzugriff (PDF)

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

Cancer medicine (Malden, MA), 2022-04, Vol.11 (8), p.1796-1804

2022

Volltextzugriff (PDF)

Treatment of central venous catheter‐associated deep venous thrombosis in cancer patients with rivaroxaban

American journal of hematology, 2017-01, Vol.92 (1), p.E9-E10

2017

Volltextzugriff (PDF)

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

The American journal of cardiology, 2017-04, Vol.120 (2), p.213-217

2017

Volltextzugriff (PDF)

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

Journal of oncology pharmacy practice, 2024-03, Vol.30 (2), p.332-341

2024

Volltextzugriff (PDF)

Integrating clinical pharmacy services into patient care in an early-phase clinical trial clinic

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18228-e18228

2017

Volltextzugriff (PDF)

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Blood, 2016-12, Vol.128 (22), p.2621-2621

2016

Volltextzugriff (PDF)

Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis

Blood, 2017-12, Vol.130, p.3296-3296

2017

Volltextzugriff (PDF)

Spotlight on nilotinib in the treatment of chronic myelogenous leukemia

Blood and lymphatic cancer, 2014-01, Vol.4 (default), p.61-67

2014

Volltextzugriff (PDF)

Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients

Journal of oncology pharmacy practice, 2009-09, Vol.15 (3), p.175-182

2009

Volltextzugriff (PDF)

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

Journal of oncology pharmacy practice, 2021-03, Vol.27 (2), p.389-394

2021

Volltextzugriff (PDF)

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK ROSI, and ALK fusion-positive solid tumors

Therapeutics and clinical risk management, 2018-01, Vol.14, p.1247

2018

Volltextzugriff (PDF)

Intensified Mycophenolate Mofetil (MMF) Dosing Every 8 Hours Is Safe From The Standpoint Of Engraftment and May Ameliorate Severe Acute Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (CBT)

Blood, 2013-11, Vol.122 (21), p.4600-4600

2013

Volltextzugriff (PDF)

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

Blood, 2013-11, Vol.122 (21), p.3297-3297

2013

Volltextzugriff (PDF)

Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation

Biology of blood and marrow transplantation, 2015-05, Vol.21 (5), p.920-925

2015

Volltextzugriff (PDF)

Safety and efficacy of dose escalated liposomal amphotericin B in adult leukemia patients with refractory invasive fungal infections: A single institution report

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6613-6613

2012

Volltextzugriff (PDF)

Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infections

P&T (Lawrenceville, N.J.), 2008-05, Vol.33 (5), p.282-288

2008

Volltextzugriff (PDF)

High Number of Successful Mobilizations Associated with the Use of Plerixafor and Colony Stimulating Factors In Patients with Multiple Myeloma (MM) and Lymphoma Treated at Memorial Sloan-Kettering Cancer Center

Blood, 2010-11, Vol.116 (21), p.2263-2263

2010

Volltextzugriff (PDF)

Retrospective Comparison of Phenytoin and Levetiracetam as Seizure Prophylaxis With High Dose Busulfan During Allogeneic Stem Cell Transplant

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S353-S353

2011

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(11)
Hematology, Oncology And Palliative Medicine
(7)
Male
(6)
Middle Aged
(6)
Oncology
(6)
Female
(5)
Patients
(5)
Retrospective Studies
(5)
Cancer
(4)
Hematology
(4)
Adult
(3)
Aged
(3)
Cancer Therapies
(3)
Clinical Trials
(3)
Drug Dosages
(3)
Kinases
(3)
Leukemia
(3)
Risk Factors
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nosocomial postsurgical meningitis in children: a 12-year survey comparing data from 1993-1998 with data from 1999-2004

Infective endocarditis in diabetic patients

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK , ROS1 , and ALK fusion-positive solid tumors

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study

Pharmacotherapy for chronic myelogenous leukemia: a case-based approach

Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

Treatment of central venous catheter‐associated deep venous thrombosis in cancer patients with rivaroxaban

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

Integrating clinical pharmacy services into patient care in an early-phase clinical trial clinic

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis

Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Spotlight on nilotinib in the treatment of chronic myelogenous leukemia

Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK ROSI, and ALK fusion-positive solid tumors

Intensified Mycophenolate Mofetil (MMF) Dosing Every 8 Hours Is Safe From The Standpoint Of Engraftment and May Ameliorate Severe Acute Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (CBT)

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation

Safety and efficacy of dose escalated liposomal amphotericin B in adult leukemia patients with refractory invasive fungal infections: A single institution report

Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infections

High Number of Successful Mobilizations Associated with the Use of Plerixafor and Colony Stimulating Factors In Patients with Multiple Myeloma (MM) and Lymphoma Treated at Memorial Sloan-Kettering Cancer Center

Retrospective Comparison of Phenytoin and Levetiracetam as Seizure Prophylaxis With High Dose Busulfan During Allogeneic Stem Cell Transplant

Suchergebnisse filtern